MEDIMI AB AK Stock Price Today

€0.00 EUR
▲ 0.00% today

MEDIMI AB AK stock price today. MEDIMI AB AK (F:79T) is currently trading at €0.00 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.00 and €0.00. This page tracks MEDIMI AB AK's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see how efficiently does MEDIMI AB AK generate cash.

Share Price of MEDIMI AB AK — Daily History & Trading Volume

Share price of MEDIMI AB AK over the past year. The chart below tracks MEDIMI AB AK's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

MEDIMI AB AK Stock Trading Volume

MEDIMI AB AK stock trading volume shows how many shares changed hands each day on the F exchange.

MEDIMI AB AK Income Statement — Revenue, Profit & Earnings by Year

MEDIMI AB AK's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €48.16K €4.81 Million €3.63 Million €2.07 Million €1.07 Million
Cost of Revenue €4.80K €3.58 Million €1.60 Million €1.51 Million €1.70 Million
Gross Profit €43.37K €1.23 Million €2.03 Million €558.34K €-633.85K
Research & Development — — — — —
SG&A — — — — €6.51 Million
Total Operating Expenses €3.25 Million €17.12 Million €17.77 Million €16.72 Million €17.41 Million
Operating Income €-3.20 Million €-12.31 Million €-14.14 Million €-14.65 Million €-16.34 Million
EBITDA — — — — —
EBIT — — — — —
Interest Expense €952.00 €364.00K €179.00K €63.37K €18.41K
Income Before Tax €-3.19 Million €-14.83 Million €-14.25 Million €-15.41 Million €-16.36 Million
Income Tax Expense — — — — —
Net Income €-3.19 Million €-14.83 Million €-14.25 Million €-15.41 Million €-16.36 Million

MEDIMI AB AK Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes MEDIMI AB AK's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €1.70 Million €10.98 Million €20.68 Million €18.09 Million €17.65 Million
Total Current Assets €295.55K €8.45 Million €16.91 Million €15.00 Million €16.74 Million
Cash & Equivalents — — — — —
Short-term Investments — — — — —
Net Receivables €29.65K €1.66 Million €978.00K €575.89K €291.83K
Inventory — €1.03 Million €2.48 Million €2.65 Million €3.03 Million
Property, Plant & Equipment — — — — —
Goodwill — — — — —
Total Liabilities €1.37 Million €6.73 Million €6.93 Million €2.84 Million €2.41 Million
Total Current Liabilities €301.69K €3.26 Million €3.49 Million €2.84 Million €2.41 Million
Long-term Debt — €2.40 Million €3.00 Million €0.00 —
Net Debt — — — — —
Total Stockholder Equity €332.69K €4.25 Million €13.75 Million €15.25 Million €15.24 Million
Retained Earnings — €-52.88 Million €-48.51 Million €-49.55 Million €-35.59 Million

MEDIMI AB AK Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how MEDIMI AB AK generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €87.95K €-11.86 Million €-12.66 Million €-13.96 Million €-16.02 Million
Capital Expenditures €97.53K €590.00K €1.37 Million €3.44 Million €636.18K
Free Cash Flow €-9.58K €-12.45 Million €-14.03 Million €-17.40 Million €-16.66 Million
Investing Cash Flow — — — — —
Financing Cash Flow — — — — —
Dividends Paid — — — — —
Stock-Based Compensation — — — — —
Depreciation — — — €559.72K €296.78K
Change in Cash €35.89K €-7.12 Million €1.66 Million €-1.98 Million €6.81 Million

MEDIMI AB AK Earnings History — EPS Actual vs. Analyst Estimates

Track MEDIMI AB AK's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 17, 2025 — — —